BTIG analysts have downgraded Globus Medical from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

In other recent news, Globus Medical reported its first-quarter 2025 financial results, revealing unexpected shortfalls in both revenue and earnings. The company posted sales of $598.1 million ...

as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position.

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Zimmer Biomet announced today that it appointed Kevin Thornal as group president, global businesses and the Americas.

On the 10th anniversary of the most dramatic Championship game in history, Neil Fissler tracks down the heroes from that ...

Fintel reports that on May 27, 2025, BTIG downgraded their outlook for Globus Medical (NYSE:GMED) from Buy to Neutral.

On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $77.5, a high ...

On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns about its Spine business. The analyst did not assign a price target ...